Lv11
40 积分 2025-02-14 加入
Abstract ND02: Discovery of BMS-986365, a ligand-directed androgen receptor degrader (AR LDD) with a dual mechanism-of-action and best-in-class potential, for the treatment of advanced prostate cancer
4个月前
已关闭
A bibliometric analysis of PROTAC from 2001 to 2021
4个月前
已完结
A new synthetic method for the framework of aspidosperma alkaloids using singlet oxygen chemistry
4个月前
已完结
Targeting CDK7 in oncology: The avenue forward
4个月前
已完结
Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7)
6个月前
已完结
皖公网安备34019202002308
